Skip to content

Salvia divinorum research published in 2006

20 studies whose primary subject is salvia divinorum were published in 2006, up from 13 in 2005. Newest first. Back to the salvia divinorum overview

Studies

Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.

Journal of Natural Products December 1, 2006 Osamu Shirota, Kumi Nagamatsu, Setsuko Sekita 68 citations

Seven new neo-clerodane diterpenes, salvidivins A (2), B, (3), C (4), and D (5), salvinorins H (6) and I (7), and divinatorin [corrected] F (8), along with eight known neo-clerodane diterpenes, salvinorins A (1)-F, divinatorins A and B, and seven other constituents, were isolated from the hallucinogenic sage Salvia divinorum. The structures of 1-7 were elucidated on the basis of 2D NMR...

DOI: 10.1021/np060456f (opens in new tab) Full text (opens in new tab) Salvia divinorum chemistry Salvia divinorum compounds Salvia divinorum phytochemistry Salvia divinorum constituents +10

Pattern of use and subjective effects of Salvia divinorum among recreational users.

Drug and Alcohol Dependence November 8, 2006 Débora González, Jordi Riba, José Carlos Bouso et al. 163 citations

Salvia divinorum is a member of the Lamiaceae family and contains the psychotropic diterpene and kappa-opioid receptor agonist salvinorin-A. Originally a shamanic inebriant used by the Mexican Mazatec Indians, the plant and its preparations are becoming increasingly popular among non-traditional users. Demographic data and information on pattern of use and subjective effects were obtained by...

Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.

Bioorganic & Medicinal Chemistry Letters November 1, 2006 David Y W Lee, Minsheng He, Lee-Yuan Liu-Chen et al.

Salvinorin A, a compound isolated from the plant Salvia divinorum, is a potent and highly selective agonist for the kappa opioid receptor. For exploration of its structure and activity relationships, further modifications, such as reduction at the C(4) position, have been studied and a series of salvinorin A derivatives were prepared. These C(4)-modified salvinorin A analogues were screened for...

Salvinorin A: from natural product to human therapeutics.

Molecular interventions October 1, 2006 Timothy A Vortherms, Bryan L. Roth 91 citations

The hallucinogenic plant Salvia divinorum (i.e., "magic mint") is a member of the Sage family that has been used for divination and shamanism by the Mazatecs. Over the past decade or so, S. divinorum has been increasingly used recreationally. The neoclerodane diterpene salvinorin A is the active component of S. divinorum, and recently, the kappa opioid receptor (KOR) has been identified, in...

DOI: 10.1124/mi.6.5.7 (opens in new tab) Full text (opens in new tab) Salvinorin a Hallucinogens Psychedelics Psychoactive compounds +15

The antinociceptive effect of salvinorin A in mice.

European Journal of Pharmacology September 18, 2006 Trentini F John, Larry G French, Joseph S Erlichman 76 citations

Salvia divinorum is a hallucinogenic plant used by the Mazatec Indians of Mexico for traditional spiritual ceremonies. The active constituent, salvinorin A, induces profound hallucinations, however the biological mechanism for this action is not known. Affinity-binding studies suggest that the biologic activity of salvinorin A involves the kappa-opioid receptor. The purpose of this study was to...

DOI: 10.1016/j.ejphar.2006.06.077 (opens in new tab) Full text (opens in new tab) Pain relief:pain reduction Alleviate discomfort Pain tolerance Analgesia +5

Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).

Bioorganic & Medicinal Chemistry Letters September 1, 2006 Cécile Béguin, Michele R Richards, Jian-Guo Li et al.

kappa-opioid receptor ligands have raised interest for their apparent effects on mood. The potent and selective kappa-agonist salvinorin A has short-lasting (15min) depressive-like effects in rats in behavioral models used to study mood disorders. Two series of salvinorin derivatives modified at C(2) and C(18), respectively, were synthesized and their kappa-opioid receptor affinities,...

Analysis of the psychoactive terpenoid salvinorin A content in five Salvia divinorum herbal products.

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy September 1, 2006 William R Wolowich, Alisha M Perkins, John J Cienki 37 citations

To determine the content of the hallucinogen salvinorin A in a variety of Salvia divinorum herbal products and to compare the content with the label claims of potency and purity. Laboratory analysis. University-affiliated laboratory. Five herbal products containing Salvia divinorum. The samples were purchased from the Internet and local drug paraphernalia shops ("head shops"). Highperformance...

Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.

Journal of Pharmacology and Experimental Therapeutics August 1, 2006 Michael Ansonoff, Jiwen Zhang, Traci A Czyzyk et al. 101 citations

Salvia divinorum is a natural occurring hallucinogen that is traditionally used by the Mazatec Indians of central Mexico. The diterpene salvinorin A was identified as an active component of S. divinorum over 20 years ago, but only recently has biochemical screening indicated that a molecular target of salvinorin A in vitro is the kappa-opioid receptor. We have examined whether salvinorin A, the...

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.

Bioorganic & Medicinal Chemistry Letters June 15, 2006 Wayne W Harding, Matthew Schmidt, Kevin Tidgewell et al.

A synthetic sequence has been developed to selectively functionalize the furan ring of the natural product salvinorin A (2a). The synthetic routes described convert the furan ring in 2a into an N-sulfonylpyrrole, oxazole or an oxadiazole. In addition, a procedure has been found to remove the furan skeleton completely. Biological results indicate that replacement of the furan ring with an...

Studies Towards the Synthesis of Salvinorin A

Australian Journal of Chemistry June 13, 2006 Anthony R. Lingham, Helmut M. Hügel, Trevor J. Rook

Salvinorin A 1, a psychoactive neoclerodane diterpenoid from the Mexican sage S. divinorum, has gained interest as a selective ?-opioid receptor agonist. Non-racemic 3-furylamines 9a and 9b have been prepared from (+)-pseudoephedrine and (–)-ephedrine for application in the stereoselective synthesis of the ketone ring of 1. Diels–Alder reaction of 9b with methyl acrylate in aqueous media,...

Synthesis of salvinorin A analogues as opioid receptor probes.

Journal of Natural Products June 2006 Kevin Tidgewell, Wayne W Harding, Anthony Lozama et al.

Several neoclerodanes, such as salvinorin A (1) and herkinorin (3), have recently been shown to possess opioid receptor activity in vitro and in vivo. To explore the structure-affinity relationships of this interesting class of compounds, we have synthesized a series of analogues from 1 isolated from Salvia divinorum. Here, we report the semisynthesis of neoclerodane diterpenes and their...

A unique binding epitope for salvinorin A, a non‐nitrogenous kappa opioid receptor agonist

FEBS Journal May 1, 2006 Brian E. Kane, Marcelo J. Nieto, Christopher R Mccurdy et al.

Salvinorin A is a potent kappa opioid receptor (KOP) agonist with unique structural and pharmacological properties. This non‐nitrogenous ligand lacks nearly all the structural features commonly associated with opioid ligand binding and selectivity. This study explores the structural basis to salvinorin A binding and selectivity using a combination of chimeric and single‐point mutant opioid...

[Salvia divinorum--representation of a new drug in the Internet].

Das Gesundheitswesen May 1, 2006 Holger Siemann, Michael Specka, Fabrizio Schifano et al. 10 citations

The German pages of the Internet were searched for the presence of the hallucinogenic herbal drug Salvia divinorum, which is not dealt with in current addiction medicine or psychiatric text books. The investigation is part of the EU sponsored project "Psychonaut" as preparatory work for the development of an Internet-based early warning system. The first 100 websites of the search using "Salvia...

Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.

Arzneimittel-Forschung 2006 D Jeremy Stewart, Hesham Fahmy, Bryan L. Roth et al.

Salvinorin A ((2S,4aR,6aR,7R,9S,10aS, 10bR)-2H-naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo methyl ester, 1, CAS 83729-01-5) has been shown to bind with high affinity and selectivity to the kappa-opioid receptor (KOR) as an agonist. Bioisosteres of 1 were developed and biologically evaluated in binding and functional assays. The C-2...

A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Journal of computer-aided molecular design 2006 Nidhi Singh, Gwénaël Chevé, David M Ferguson et al.

Combined ligand-based and target-based drug design approaches provide a synergistic advantage over either method individually. Therefore, we set out to develop a powerful virtual screening model to identify novel molecular scaffolds as potential leads for the human KOP (hKOP) receptor employing a combined approach. Utilizing a set of recently reported derivatives of salvinorin A, a structurally...

Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats.

Journal of Pharmacology and Experimental Therapeutics January 2006 William A Carlezon, Cécile Béguin, Jennifer A DiNieri et al.

Endogenous opioids seem to play a critical role in the regulation of mood states. For example, there is accumulating evidence that stimulation of kappa-opioid receptors, upon which the endogenous opioid dynorphin acts, can produce depressive-like behaviors in laboratory animals. Here we examined whether systemic administration of salvinorin A (SalvA), a potent and highly selective kappa-opioid...

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.

Neurogastroenterology & Motility 2006 Raffaele Capasso, Francesca Borrelli, F Capasso et al. 56 citations

Salvia divinorum is a widespread hallucinogenic herb traditionally employed for divination, as well as a medicament for several disorders including disturbances of gastrointestinal motility. In the present study we evaluated the effect of a standardized extract from the leaves of S. divinorum (SDE) on enteric cholinergic transmission in the guinea-pig ileum. SDE reduced electrically evoked...

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.

Journal of Natural Products 2006 Wayne W Harding, Matthew Schmidt, Kevin Tidgewell et al. 59 citations

Salvinorin A (1) is a hallucinogenic neoclerodane diterpene isolated from the widely available psychoactive plant Salvia divinorum and is the first example of a non-nitrogenous opioid receptor ligand. At present, there is little information available as to why this compound is selective for kappa opioid receptors. One approach to better understanding the mode of binding of 1 at kappa receptors...

DOI: 10.1021/np050398i (opens in new tab) Full text (opens in new tab) Salvinorin a research Unique hallucinogen Compound 10a Neoclerodane diterpene +5